Fahd Riaz focuses his practice on corporate counselling and finance transactions, mergers and acquisitions, partnering, licensing and commercial transactions.

Fahd clients range from emerging growth companies to Fortune 50 companies, specifically in life sciences and technology. He has served as lead counsel for pharmaceutical, biotech and device companies and major Universities in a number of large life sciences industry transactions, in the United States, Europe and Asia, including large collaborations and M&A. He uses his skillset, including his technical background as a molecular biologist and former technology industry experience in fulfilling the special business and legal needs of public and private life science and technology companies as they seek to form joint ventures, partnerships and other complex collaborations, acquire venture capital financing, and execute mergers, acquisitions and licensing transactions.

Related matters include negotiation and drafting of technical contractual arrangements related to the conducting and outsourcing of drug discovery, clinical trials, development, manufacturing and supply, distribution, marketing and promotion. He serves as outside general counsel for clients and advises boards of directors on disclosure issues, corporate communication policies and fiduciary duty matters.

He also is an avid supporter of entrepreneurs and emerging growth companies. He becomes involved early with entrepreneurs and emerging growth companies in the development of strategies for success for such parties.